Literature DB >> 28583633

Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality.

T Ullrich1, M Quentin2, C Oelers3, F Dietzel4, L M Sawicki5, C Arsov6, R Rabenalt7, P Albers8, G Antoch9, D Blondin10, H J Wittsack11, L Schimmöller12.   

Abstract

OBJECTIVES: This study prospectively evaluates objective image quality (IQ), subjective IQ, and PI-RADS scoring of prostate MRI at 3.0T (3T) and 1.5T (1.5T) within the same patients.
METHODS: Sixty-three consecutive patients (64±9years) were prospectively included in this non-inferiority trial, powered at 80% to demonstrate a ≤10% difference in signal-to-noise (SNR) and contrast-to-noise ratio (CNR) of T2-weighted and diffusion-weighted imaging (T2WI, DWI) at 1.5T compared to 3T. Secondary endpoints were analysis of subjective IQ and PI-RADS v2 scoring.
RESULTS: All patients received multi-parametric prostate MRI on a 3T (T2WI, DWI, DCE) and bi-parametric MRI (T2WI, DWI) on a 1.5T scanner using body coils, respectively. SNR and CNR of T2WI were similar at 1.5T and 3T (p=0.7-1), but of DWI significantly lower at 1.5T (p<0.01). Subjective IQ was significantly better at 3T for both, T2WI and DWI (p<0.01). PI-RADS scores were comparable for both field strengths (p=0.05-1). Inter-reader agreement was excellent for subjective IQ assessment and PI-RADS scoring (k=0.9-1).
CONCLUSION: Prostate MRI at 1.5T can reveal comparable objective image quality in T2WI, but is inferior to 3T in DWI and subjective IQ. However, similar PI-RADS scoring and thus diagnostic performance seems feasible independent of the field strength even without an endorectal coil.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Image quality; Magnetic field strength; Prostate MRI; Prostate cancer

Mesh:

Year:  2017        PMID: 28583633     DOI: 10.1016/j.ejrad.2017.02.044

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  23 in total

Review 1.  Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Authors:  Armando Stabile; Francesco Giganti; Andrew B Rosenkrantz; Samir S Taneja; Geert Villeirs; Inderbir S Gill; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2019-07-17       Impact factor: 14.432

2.  Role of MRI for the detection of prostate cancer.

Authors:  Richard C Wu; Amir H Lebastchi; Boris A Hadaschik; Mark Emberton; Caroline Moore; Pilar Laguna; Jurgen J Fütterer; Arvin K George
Journal:  World J Urol       Date:  2021-01-04       Impact factor: 4.226

3.  Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?

Authors:  Daniel Junker; Fabian Steinkohl; Veronika Fritz; Jasmin Bektic; Theodoros Tokas; Friedrich Aigner; Thomas R W Herrmann; Michael Rieger; Udo Nagele
Journal:  World J Urol       Date:  2018-08-04       Impact factor: 4.226

Review 4.  Developing a National Center of Excellence for Prostate Imaging.

Authors:  Annerleim Walton-Diaz; Manuel Madariaga-Venegas; Nicolas Aviles; Juan Carlos Roman; Ivan Gallegos; Mauricio Burotto
Journal:  Curr Urol Rep       Date:  2019-09-02       Impact factor: 3.092

5.  Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.

Authors:  T Ullrich; M Quentin; A K Schmaltz; C Arsov; C Rubbert; D Blondin; R Rabenalt; P Albers; G Antoch; L Schimmöller
Journal:  Eur Radiol       Date:  2017-07-07       Impact factor: 5.315

6.  Evaluation of systematic prostate biopsies when performing transperineal MRI/TRUS fusion biopsy with needle tracking-what is the additional value?

Authors:  Jakob Schlegel; Stefan Hinz; Karsten Günzel; Ahmed Magheli; Jonas Busch; Eduard Baco; Hannes Cash; Stefan Heinrich; Daniela Edler; Martin Schostak; Hendrik Borgmann
Journal:  Int Urol Nephrol       Date:  2022-07-25       Impact factor: 2.266

7.  Diagnostic Accuracy of a MR Protocol Acquired with and without Endorectal Coil for Detection of Prostate Cancer: A Multicenter Study.

Authors:  Borna K Barth; Niels J Rupp; Alexander Cornelius; Daniel Nanz; Rainer Grobholz; Martin Schmidtpeter; Peter J Wild; Daniel Eberli; Olivio F Donati
Journal:  Curr Urol       Date:  2019-03-08

Review 8.  Advances in prostate cancer imaging.

Authors:  Matthew R Tangel; Ardeshir R Rastinehad
Journal:  F1000Res       Date:  2018-08-24

9.  Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.

Authors:  Armando Stabile; Francesco Giganti; Veeru Kasivisvanathan; Gianluca Giannarini; Caroline M Moore; Anwar R Padhani; Valeria Panebianco; Andrew B Rosenkrantz; Georg Salomon; Baris Turkbey; Geert Villeirs; Jelle O Barentsz
Journal:  Eur Urol Oncol       Date:  2020-03-17

10.  Effects of Echo Time on IVIM Quantification of the Normal Prostate.

Authors:  Zhaoyan Feng; Xiangde Min; Liang Wang; Xu Yan; Basen Li; Zan Ke; Peipei Zhang; Huijuan You
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.